This article was originally published in Start Up
Many think that British biotech is a disaster waiting to happen. The four companies profiled in this issue are attempting to establish themselves as product-driven companies, run by professional managers.
You may also be interested in...
Quantase Ltd., formed through a management buyout of Shield Diagnostic Group's neonatal diagnostics unit, is looking to expand into the neonatal home testing and pre-natal screening markets.
Can Dolly the sheep bring home the bacon? Roslin Bio-Med has licensed nuclear transfer technology from the Roslin Institute to develop transgenic pigs from which the start-up hopes to obtain organs for transplant and blood products.
Profile of company developing prostate cancer vaccine.